Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Esmolol for POCD in Middle Ear Surgery
NCT03892512Phase 2Unknown
- Sponsor
- Beni Suef University
- Start
- Apr 2019
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexmedetomidine and esmolol in Post-operative cognitive dysfunction (POCD), sponsored by Beni Suef University. Primary endpoint: Mini-Mental State Examination at 24 hours. Status: unknown.
02
Drugs
dexmedetomidineesmolol
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT03892512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03892512.